American Academy of Clinical Toxicology Practice Guidelines on the Treatment of Ethylene Glycol Poisoning

1999 ◽  
Vol 37 (5) ◽  
pp. 537-560 ◽  
Author(s):  
Heather Miller ◽  
Donald G. Barceloux ◽  
Edward P. Krenzelok ◽  
Kent Olson ◽  
William Watson
2002 ◽  
Vol 40 (4) ◽  
pp. 415-446 ◽  
Author(s):  
The American Academy of Clinical To ◽  
Donald G. Barceloux ◽  
G. Randall Bond ◽  
Edward P. Krenzelok ◽  
Hannah Cooper ◽  
...  

2013 ◽  
Vol 415 ◽  
pp. 107-108 ◽  
Author(s):  
Paul Van hee ◽  
Hugo Neels ◽  
Mireille De Doncker ◽  
Kristof E. Maudens ◽  
Willy Lambert ◽  
...  

Toxins ◽  
2020 ◽  
Vol 12 (5) ◽  
pp. 332 ◽  
Author(s):  
Lauren L. Spiegel ◽  
Jill L. Ostrem ◽  
Ian O. Bledsoe

In 2016, the American Academy of Neurology (AAN) published practice guidelines for botulinum toxin (BoNT) in the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache. This article, focusing on dystonia, provides context for these guidelines through literature review. Studies that led to Food and Drug Administration (FDA) approval of each toxin for dystonia indications are reviewed, in addition to several studies highlighted by the AAN guidelines. The AAN guidelines for the use of BoNT in dystonia are compared with those of the European Federation of the Neurological Societies (EFNS), and common off-label uses for BoNT in dystonia are discussed. Toxins not currently FDA-approved for the treatment of dystonia are additionally reviewed. In the future, additional toxins may become FDA-approved for the treatment of dystonia given expanding research in this area.


2019 ◽  
Vol 23 (4) ◽  
Author(s):  
Anna Wierzbicka-Rot ◽  
Artur Gadomski

In February 2019 American Academy of Otolaryngology-Head and Neck Surgery published clinical practice guidelines which provides evidence-based recommendations that applies to children under consideration for tonsillectomy. This update to the 2011 publication includes large amount of new, practical information about pre-, intra- and postoperative care and management, that can be useful for surgeons as well as GPs and pediatricians


2018 ◽  
Vol 290 ◽  
pp. e9-e14 ◽  
Author(s):  
Gaspar Tuero ◽  
Jesús González ◽  
Laura Sahuquillo ◽  
Anna Freixa ◽  
Isabel Gomila ◽  
...  

1978 ◽  
Vol 18 (2) ◽  
pp. 102-107 ◽  
Author(s):  
D. A. L. Bowen ◽  
P.S. B. Minty ◽  
A. Sengupta

Two cases of self poisoning by ethylene glycol are reported. The salient features of fatal acute ethylene glycol poisoning are mentioned with detailed histological and toxicological findings. Gas chromatographic analysis was used to determine ethylene glycol levels in serum and urine.


2019 ◽  
Vol 161 (1) ◽  
pp. 3-5
Author(s):  
Andrés M. Bur ◽  
Richard M. Rosenfeld

Clinical practice guidelines (CPGs), developed to inform clinicians, patients, and policy makers about what constitutes optimal clinical care, are one way of increasing implementation of evidence into clinical practice. Many factors must be considered by multidisciplinary guideline panels, including strength of available evidence, limitations of current knowledge, risks/benefits of interventions, patient values, and limited resources. Grading of Recommendations Assessment, Development and Evaluation (GRADE) is a framework for summarizing evidence that has been endorsed by many national and international organizations for developing CPGs. But is GRADE the right choice for CPGs developed by the American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF)? In this commentary, we will introduce GRADE, discuss its strengths and limitations, and address the question of what potential benefits GRADE might offer beyond existing methodology used by the AAO-HNSF in developing CPGs.


Sign in / Sign up

Export Citation Format

Share Document